Therapeutic Innovation & Regulatory Science (TIRS) is the official scientific journal of DIA that strives to advance medical product discovery, development, regulation, and use through the publication of peer-reviewed original and review articles, commentaries, and letters to the editor across the spectrum of converting biomedical science into practical solutions to advance human health.
The focus areas of the journal are as follows:
Biostatistics
Clinical Trials
Product Development and Innovation
Global Perspectives
Policy
Regulatory Science
Product Safety
Special Populations
《Therapeutic Innovation & Regulatory Science》是一本由SPRINGER HEIDELBERG出版商出版的专业医学期刊,该刊创刊于1997年,刊期6 issues per year,该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 4区,小类学科:医学:信息 4区;药学 4区;在JCR(Journal Citation Reports)分区等级为Q4。该刊发文范围涵盖医学:信息等领域,旨在及时、准确、全面地报道国内外医学:信息工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为1.337,
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 4区 | MEDICAL INFORMATICS 医学:信息 PHARMACOLOGY & PHARMACY 药学 | 4区 4区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q4 | MEDICAL INFORMATICS | Q4 | 1.337 |
PHARMACOLOGY & PHARMACY | Q4 |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
1.337 | 12 | 22.87% | 80.39% | 未开放 | -- |